Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
18.35
+0.97 (5.58%)
Aug 13, 2026, 1:26 PM EDT - Market open
IART Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 214.42 | 235.05 | 246.38 | 276.4 | 456.66 | 513.45 |
Short-Term Investments | 59.67 | 28.69 | 27.19 | 32.69 | - | - |
Cash & Short-Term Investments | 274.08 | 263.74 | 273.57 | 309.1 | 456.66 | 513.45 |
Cash Growth | 8.07% | -3.59% | -11.49% | -32.31% | -11.06% | 9.21% |
Accounts Receivable | 267.19 | 278.85 | 272.37 | 259.33 | 263.47 | 231.83 |
Inventory | 492.01 | 492.74 | 429.09 | 389.61 | 324.58 | 317.39 |
Other Current Assets | 158.21 | 124.22 | 106.65 | 100.01 | 116.79 | 91.05 |
Total Current Assets | 1,191 | 1,160 | 1,082 | 1,058 | 1,161 | 1,154 |
Net Property, Plant & Equipment | 583.29 | 584.9 | 549.77 | 496.38 | 459.59 | 396.25 |
Other Intangible Assets | 1,076 | 1,135 | 1,208 | 1,068 | 1,127 | 1,146 |
Goodwill | 611.15 | 615.16 | 1,097 | 1,055 | 1,039 | 1,013 |
Other Long-Term Assets | 102.03 | 107.73 | 101.44 | 104.27 | 103.18 | 73.39 |
Total Assets | 3,563 | 3,602 | 4,037 | 3,782 | 3,890 | 3,782 |
Accounts Payable | 82.64 | 95.73 | 82.5 | 92.33 | 102.1 | 61.84 |
Accrued Expenses | 175.8 | 204.57 | 207.53 | 176.3 | 158.8 | 213.11 |
Short-Term Debt | - | - | 573.17 | - | - | - |
Current Portion of Long-Term Debt | 43.59 | 126.55 | 33.91 | 14.53 | 38.13 | 45 |
Current Portion of Leases | 13.92 | 14.02 | 14.54 | 15.28 | 14.62 | 14.78 |
Unearned Revenue | 11.7 | 11.46 | 10.48 | 8.54 | 7.25 | 5.3 |
Other Current Liabilities | 3.24 | 3.65 | - | - | - | - |
Total Current Liabilities | 330.88 | 455.98 | 922.13 | 306.98 | 320.91 | 340.02 |
Long-Term Debt | 1,829 | 1,730 | 1,196 | 1,485 | 1,405 | 1,501 |
Long-Term Leases | 162.66 | 163.06 | 166.93 | 166.85 | 157.42 | 90.33 |
Other Long-Term Liabilities | 197.87 | 209.94 | 207.07 | 235.26 | 201.84 | 166.05 |
Total Long-Term Liabilities | 2,189 | 2,103 | 1,570 | 1,887 | 1,764 | 1,758 |
Total Liabilities | 2,520 | 2,559 | 2,492 | 2,194 | 2,085 | 2,098 |
Common Stock | 0.92 | 0.92 | 0.92 | 0.91 | 0.91 | 0.9 |
Treasury Stock | -686.92 | -689.21 | -691.41 | -647.26 | -362.86 | -234.45 |
Additional Paid-in Capital | 1,346 | 1,338 | 1,323 | 1,302 | 1,277 | 1,265 |
Accumulated Other Comprehensive Income | -40.2 | -30.08 | -27.57 | -15.11 | 10.27 | -45.16 |
Retained Earnings | 423.31 | 423.44 | 939.92 | 946.86 | 879.12 | 698.57 |
Shareholders' Equity | 1,043 | 1,043 | 1,545 | 1,588 | 1,804 | 1,685 |
Total Liabilities & Equity | 3,563 | 3,602 | 4,037 | 3,782 | 3,890 | 3,782 |
Total Debt | 2,049 | 2,033 | 1,985 | 1,682 | 1,615 | 1,651 |
Net Cash (Debt) | -1,775 | -1,769 | -1,711 | -1,373 | -1,159 | -1,138 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -23.00 | -23.08 | -22.22 | -17.09 | -13.87 | -13.31 |
Book Value | 1,043 | 1,043 | 1,545 | 1,588 | 1,804 | 1,685 |
Book Value Per Share | 13.52 | 13.61 | 20.07 | 19.77 | 21.61 | 19.71 |
Tangible Book Value | -643.31 | -706.36 | -759.26 | -535.41 | -361.09 | -474.23 |
Tangible Book Value Per Share | -8.34 | -9.21 | -9.86 | -6.66 | -4.32 | -5.55 |